| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2111798
Max Phase: Preclinical
Molecular Formula: C28H26N2O5
Molecular Weight: 470.53
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCc1c(C(=O)C(N)=O)c2cc(OCCC(=O)O)ccn2c1Cc1ccccc1-c1ccccc1
Standard InChI: InChI=1S/C28H26N2O5/c1-2-21-23(16-19-10-6-7-11-22(19)18-8-4-3-5-9-18)30-14-12-20(35-15-13-25(31)32)17-24(30)26(21)27(33)28(29)34/h3-12,14,17H,2,13,15-16H2,1H3,(H2,29,34)(H,31,32)
Standard InChI Key: NHAAMMHRYGBJBY-UHFFFAOYSA-N
Associated Targets(Human)
Phospholipase A2 group 1B 720 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 470.53 | Molecular Weight (Monoisotopic): 470.1842 | AlogP: 4.28 | #Rotatable Bonds: 10 |
| Polar Surface Area: 111.10 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.62 | CX Basic pKa: | CX LogP: 4.34 | CX LogD: 1.00 |
| Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.27 | Np Likeness Score: -0.29 |
References
| 1. Hagishita S, Yamada M, Shirahase K, Okada T, Murakami Y, Ito Y, Matsuura T, Wada M, Kato T, Ueno M, Chikazawa Y, Yamada K, Ono T, Teshirogi I, Ohtani M.. (1996) Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives., 39 (19): [PMID:8809154] [10.1021/jm960395q] |
Source
Source(1):